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Na+,K+-adenosine triphosphatase (NKA) is the first P-type ion translocating adenosine triphosphatase
(ATPase) ever identified, and the significance of this class of proteins was highlighted by the 1997 Nobel Prize
in Chemistry awarded to Jens C. Skou for the discovery in 1957. More than half a century passed between the
initial identification and the publication of a high-resolution crystal structure of NKA. Although the new crystal
structures provided many surprises and insights, structural biology on this system remains challenging, as
NKA is a very difficult protein to crystallize. Here we explain the reasons behind the challenges, introduce
a mechanism that governs the function, and summarize current knowledge of NKA structure in comparison
with another member of the P-type ATPase family, Ca2+-ATPase.Introduction
Na+,K+-adenosine triphosphatase (NKA; Skou, 1957) is the most
prominent member of the P-type adenosine triphosphatase
(ATPase) family that includes sarcoplasmic reticulum Ca2+-
ATPase (SERCA) and gastric H+,K+-ATPase, among others.
NKA pumps three Na+ ions out and two K+ ions into the cell
per molecule of ATP hydrolysed and thereby creates concentra-
tion gradients across the plasma membrane. It is primarily a Na+
ion pump, as K+ can be substituted equally well with other mono-
valent metal ions (including Na+ itself) and even organic cations
(Ratheal et al., 2010), whereas only Li+ and H+ can substitute
partially for Na+ (Blostein, 1985). Because transported K+ ions
dissipate through the K+-channel, the resting membrane poten-
tial is determined mainly by the K+ conductance of the mem-
brane. On the other hand, SERCA countertransports protons,
which do not accumulate in the cytoplasm and are presumably
dissipated through H+ channels. The gradients of Na+ and K+
ions created and maintained by NKA are used for many
purposes, including the generation of action potentials along
nerves, and as an energy source for secondary active transport.
NKA is expressed in all animal cells and is finely regulated. In
addition to the catalytic unit (the a-subunit) of approximately
1,000 residues, which is also found in SERCA, NKA contains
a heavily glycosylated b-subunit of about 300 residues and
a tissue-specific auxiliary regulatory subunit of approximately
70-180 residues. The latter are known as FXYD proteins and
modulate NKA function according to the specific demands of
a given tissue. Originally, the isoform expressed in kidney
(FXYD2) was called the g-subunit, and that expressed mainly
in heart (FXYD1) was referred to as phospholemman. In humans,
there are four isoforms for the a-subunit, three for the b-subunit,
and seven for FXYD, leading to different NKA variants.
NKA is the target for cardiotonic steroids (CTS) or cardiac
glycosides, such as digoxin, which has been used in the treat-
ment of congestive heart failure for more than two centuries.
The CTS binding site of NKA is highly conserved, whichmay indi-
cate a fundamental role in the regulation of physiological
processes (Lingrel, 2010). Such a ‘‘receptor function’’ of NKA1732 Structure 19, December 7, 2011 ª2011 Elsevier Ltd All rights reand its regulation by potential endogenous CTS have attracted
much attention recently (Schoner and Scheiner-Bobis, 2007).
There are now many reports that demonstrate interactions of
NKA with other proteins, such as IP3 receptor, Src kinase, and
agrin, suggesting formation of large signal complexes regulated
by CTS (Figure 1B; Prassas and Diamandis, 2008). Furthermore,
NKA is now regarded as a key player in cell adhesion, as the
b-subunit was shown to act as a K+-dependent lectin. Finally,
aberrant expression and activity of NKA may be implicated in
the development and progression of various cancers (Mijatovic
et al., 2007). Thus, NKA is now recognized as an important
therapeutic target (Prassas and Diamandis, 2008).
As seen from the brief discussion of NKA physiological func-
tion, NKA is a complex system that is pivotal in the regulation
of cell homeostasis. Here, we introduce the NKA reaction cycle,
then describe the results of recent structural work and discuss
their functional implications.
The Reaction Cycle
The reaction cycle of P-type ATPases is explained by the Post-
Albers scheme (Albers, 1967; Post et al., 1972) or E1/E2 theory
(Figure 1, inset). Here, pumping action is achieved by alternating
the affinity and the accessibility of the transmembrane (TM)
cation binding sites (see Glynn, 1993 and Kaplan, 2002, for
reviews). In the E1 species (e.g., E1$3Na+), the TM cation binding
sites have high affinity for Na+ and face the cytoplasm, whereas
in E2, the binding sites have low affinity for Na+ but high affinity
for K+ and face the extracellular side. To ensure vectorial trans-
port and to avoid channel-like short circuit, the system is
expected to have two gates, one on the cytoplasmic side and
the other on the extracellular side (Gadsby, 2009). The two
gates must operate in strict coordination, and the reaction cycle
must contain a step in which both gates are closed so that the
TM binding sites become inaccessible from either side of the
membrane (i.e., ‘‘occluded’’ state). The hallmark of P-type
ATPases is autophosphorylation and –dephosphorylation of
the catalytic aspartate during the reaction cycle. Only after
three Na+ ions are bound is the cytoplasmic gate closed andserved
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Figure 1. Architecture of Na+,K+-ATPase
from Shark Rectal Gland with BoundMgF4
2–
and K+, a Stable Analog of the E2$Pi$2K
+
State
(A) A ribbon diagram of NKA with ouabain (shown
in space fill) bound at low affinity (PDB ID: 3A3Y).
Color changes gradually from the N-terminal (blue)
to the C-terminal (red). ATP is taken from the
E2(TG)$ATP crystal structure of Ca2+-ATPase
(SERCA1a) (PDB ID: 3AR4) and docked in the
corresponding position. Bound K+ ions are
marked (I, II, and C) and circled. Inset shows
a simplified diagram of the Post-Albers scheme.
CLR, cholesterol; OBN, ouabain.
(B) Digestion sites (proteinase K, black ‘‘x’’;
chymotrypsin, magenta ‘‘x’’) and interaction sites
with other proteins (dotted circles). Residue
numbers in parentheses refer to corresponding
residues in SERCA1a. AP-2, adaptor protein 2;
IP3R, inositol 1,4,5-triphosphate receptor; PI3K,
phophoinositide-3 kinase.
(C) Disposition of transmembrane helices viewed
approximately perpendicular to the membrane
from the cytoplasmic side (NKA, yellow;
SERCA1a, cyan). CLR, cholesterol.locked by phosphoryl transfer to the aspartate (i.e., transition
into the E1P state). In the E1P state, bound Na+ ions are
occluded (sometimes denoted as E1P[3Na+]). During the transi-
tion to E2P, the extracellular gate opens, and three Na+ ions are
released sequentially. Then, the ions to be countertransported
(normally 2 K+) occupy the binding sites. The extracellular gate
is closed by the hydrolysis of the aspartylphosphate and locked
in E2$2K+. This is a stable state, and the transition into E1 is very
slow without ATP. On the other hand, SERCA countertransports
2-3 H+, but E2 (E2$nH+ in rigorous notation) is only a transient
state at pH 7, and the release of H+ occurs spontaneously (see
Toyoshima, 2008, for a review). Yet acceleration by ATP (and
ADP) is observed with both pumps.
The use of various metal fluorides as stable phosphate
analogs allows distinction of the ground (BeF3
), transition
(AlF4
) and product (MgF4
2) states in the hydrolysis of the
aspartylphosphate. Retrospectively, a combined use of metal
fluorides and limited proteolysis with proteinase K, in particular
(Danko et al., 2001a, 2001b), produced a breakthrough in under-
standing of the mechanism of ion pumping by SERCA1a. With
NKA, it is only very recently that such systematic studies have
been started (Figure 1B; Cornelius et al., 2011).
Structural Studies
Compared to SERCA1a, for which more than 20 crystal struc-
tures have been published covering almost the entire reaction
cycle (Toyoshima, 2008), structural understanding of ion pump-
ing by NKA is still rather limited, as only four crystal structures
have been reported for NKA at better than 5 A˚ resolutionStructure 19, December 7, 2011 ªcovering essentially just two states.
Two are analogs of E2$Pi$2K
+—namely,
E2$2Rb+$MgFx crystal of pig kidney
enzyme at 3.5 A˚ resolution (Protein Data
Bank [PDB] ID: 3B8E; Morth et al., 2007)
and E2$2K+$MgF4
2 crystal of shark
rectal gland enzyme at 2.4 A˚ resolution(PDB ID: 2ZXE; Shinoda et al., 2009); the other two are the
low-affinity ouabain bound form E2$2K+$MgF4
2$ouabain at
2.8 A˚ resolution (PDB ID: 3A3Y; Ogawa et al., 2009), and the
high-affinity ouabain bound form E2P$nH+$ouabain at 4.6 A˚
resolution (PDB ID: 3N23; Yatime et al., 2011). Consequently,
the crystal structure of E1(P) remains currently unavailable.
There are a number of interesting differences between NKA
and SERCA1a that await structural explanation. For instance,
the turnover number of NKA ismuch larger than that of SERCA1a
(200 versus 30 at 37C). How is the extra speed achieved? How
can different ions be selected using almost identical residues?
The answer may have something to do with the b-subunit, as it
is present only in NKA andH+,K+-ATPase, both of which counter-
transport K+—but if so, what is the mechanism? The crystal
structure at 2.4 A˚ resolution (Shinoda et al., 2009) provided at
least partial answers (see the sections The a-Subunit Headpiece
and The K+-Binding Sites).
Experimentally, NKA has a number of advantages over
SERCA1a for studying reaction intermediates, as K+ is the
countertransported ion. Also, it is possible to keep the ion
pathway open with palytoxin (Artigas and Gadsby, 2003).
Many electrophysiology studies can be carried out in conjunc-
tion with structural studies. However, it should be emphasized
that crystallization of NKA remains very difficult, despite
advances in technology for crystallization of P-type ATPase
since the first publication of the SERCA1a crystal structure
(Toyoshima et al., 2000). There are several reasons for this.
First, the content of NKA in plasma membrane is substantially
less than that of SERCA1a in skeletal muscle sarcoplasmic2011 Elsevier Ltd All rights reserved 1733
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Figure 2. K+-Binding Sites and Contribution of the b-Subunit
(A and B) Details of the K+-binding sites in NKA viewed along the M5 helix from the cytoplasmic side (A) and approximately parallel to the membrane (B). Side
chains of Ca2+ coordinating residues (and themain chain of M5 in B) in SERCA1a are depicted with thin violet lines. Spheres represent K+ (purple) and water (red).
Cyan spheres show the positions of bound Ca2+ in the E1$2Ca2+ state of SERCA1a (PDB ID: 1SU4). The double-headed arrow in (B) depicts steric clash expected
between site I K+ and Asn768 amide in SERCA1a (corresponding to Asn783 in NKA).
(C) Details around the unwound part of M7. Y1023 is the C-terminal residue and is likely to form hydrogen bonds with N846 on the L6/7 loop. CLR, cholesterol.reticulum membrane, thus impacting sample homogeneity. This
problem is exacerbated by the fact that, unlike SERCA1a, which
can be purified by one-step dye affinity chromatography (Coll
and Murphy, 1984), there is no efficient purification method
established for NKA. Accordingly, the NKA currently used for
crystallization is extracted from purified membrane, limiting the
protein source to tissues that exclusively expresses the a1 iso-
form, such as kidney and shark rectal glands. Yet preparation
from kidney suffers from the presence of splice variants of the
FXYD protein (see Morth et al., 2007). Second, large-scale
production of recombinant NKA is challenging, although
systems using yeast (Pichia pastoralis) (Cohen et al., 2005) or
insect cells (Blanco, 2005) have been developed. Third, the
b-subunit is heavily and heterogeneously glycosylated, imposing
serious limitations on the ability to obtain homogeneous
samples. Next, a special lipid environment may be needed,
including a high concentration (40 mol%) of cholesterol (and
phosphatidylserine for human NKA), to stabilize NKA for struc-
tural studies (Cornelius et al., 2003; Cohen et al., 2005). The
high cholesterol content is likely to impact fluidity of the
membrane and hence limits the temperature range for crystalli-
zation. Furthermore, the composition of phospholipids and
cholesterol varies from preparation to preparation, making it
difficult to control protein/lipid ratio, one of the important para-
meters in crystallization. Additionally, the lack of very high-
affinity inhibitors that strictly fix the enzyme in one particular
conformation (e.g., thapsigargin for SERCA [Kd of pM range])
poses some limitations (see the section Binding Site of Cardio-
tonic Steroids). Next, low affinity of monovalent cations, with
apparent Kd for cytoplasmic Na
+ of 0.6 mM and that for extra-
cellular K+ of 0.2 mM, which is two orders lower affinity than
that of Ca2+ binding to SERCA1a, causes serious problems in
crystallizing NKA in ion-bound forms. This is because crystalliza-
tion will only be successful if, for example, the ATPase assumes
the same conformation >99.99% of the time (population). Lastly,
NKA may be intrinsically more fluctuating than SERCA1a
to achieve a much larger turnover rate (see the section The
a-Subunit Headpiece). Limited proteolysis with PrtK indicating1734 Structure 19, December 7, 2011 ª2011 Elsevier Ltd All rights rea much looser conformation of the NKA headpiece (Cornelius
et al., 2011) supports this idea.
Architecture of NKA: The a-Subunit
The NKA a-subunit is the catalytic subunit, which consists of
three cytoplasmic domains, actuator (A), nucleotide binding
(N), and phosphorylation (P), and ten transmembrane helices
(M1-M10), the same as seen for SERCA1a (Figure 1). Specific
to NKA is a lysine-rich N-terminal extension of approximately
40 residues that undergoes phosphorylation by protein kinase
C, and possibly serves as a platform for interacting with other
proteins, such as IP3 receptor (Figure 1B). This extension is
not yet resolved by crystallographic methods. The C-terminal
region of the NKA a-subunit is also eight residues longer than
the corresponding region in SERCA1a and forms a short helix-
like segment (Figure 2C). As this segment is connected to M5
and the loop connecting the M6 and M7 helices, L6/7, it is
expected to move during the reaction cycle (Shinoda et al.,
2009) and affect affinity for Na+ (Morth et al., 2007).
The a-Subunit Headpiece
The most surprising observation about the cytoplasmic domains
is that the headpiece is not as compact as that in SERCA1a,
which might be related to difference in the turnover numbers of
the reaction cycle. In NKA, the N-domain is less (20) inclined
toward the A-domain, and there is only one link between them:
a salt bridge between Arg551 in the N-domain and Glu223 in
the A-domain (Figure 1A). Because Arg551 is expected to
interact with the b-phosphate of ATP, it is likely that ATP/ADP
binding will break the link and accelerate the opening of the
headpiece (Shinoda et al., 2009). This opening of the headpiece
is likely to be a key event required in transition into E1.
Disposition of a-Subunit TM Helices
Of the ten TM helices, M4-M6 and M8, which directly coordinate
cations, have positions and paths very similar to those in
SERCA1a under corresponding conditions. Other helices take
similar positions but different paths. The M7-M10 helices, which
appear as a mere anchor to the membrane and do not undergo
large conformational changes in SERCA1a, have specialserved
functions and may undergo large-scale rearrangements in NKA.
In particular, the cytoplasmic half of M7 is distinctly kinked in
NKA (see later for the reason). The outside of M9 (i.e., opposite
to M2) interacts with FXYD, whereas M10 associates with the
TM helix of the b subunit (Figure 1C).
The K+-Binding Sites
With the crystal structure of NKA in the E2$2K+$MgF4
2 state,
one of the most fundamental issues of ion pumps can be
addressed: why is NKA able to bind K+ and many other monova-
lent cations, including organic ones, whereas SERCA binds
only H+, even though the residues in the binding sites are
almost identical? Analysis of the 2.4 A˚ crystal structure of NKA
provided a potential explanation for these observations. The
structure shows that two K+ ions are juxtaposed within a very
short distance (4.0 A˚; as compared to 6.0 A˚ between two Ca2+
in SERCA1a) with no bridging oxygen (Figure 2A), in marked
contrast to the KcsA K+-channel. In the selectivity filter of
KcsA, K+ ions are positioned at a 6.5 A˚ interval, separated by
a water molecule (Zhou et al., 2001). Presumably such close
disposition of metal ions is allowed for monovalent ions only.
Compared to Ca2+ in SERCA1a, both K+ are shifted (2.0 A˚)
toward M5, although K+ is substantially larger than Ca2+ (ionic
radius: 1.35 A˚ for K+, 0.99 A˚ for Ca2+). This is becausemain-chain
carbonyls are used in both sites. There is a seemingly important
acidic residue in each site (Asp815 for site I and Glu334 for
site II), but its contribution is only marginal. This exclusion of
acidic residues might be needed for accommodating two
monovalent ions, as both residues contribute to Ca2+ binding
in SERCA1a.
When NKA structure is compared to SERCA1a, coordination
geometry of bound cations is rather distorted, implying that the
affinity would not be very high. At site I of NKA, which corre-
sponds to the binding site for first Ca2+ in SERCA1a, oxygen
atoms of three side chains and one main chain plus one water
molecule contribute to metal ion (i.e., K+, Rb+ and Tl+) coordina-
tion; at site II, four side chains plus twomain-chain oxygen atoms
contribute. Calculated partial valence is a useful means for
prediciting the affinity of metal binding sites (Nayal and Di
Cera, 1994). In the crystal structure of NKA in E2$2K+$MgF4
2
(Shinoda et al., 2009), it is not much different between K+ and
Na+ and is rather small for site II, showing that these sites are
not very selective for K+. Indeed, the selectivity for K+ over Na+
is only 20- to 30-fold. Thus, the crystal structure corroborates
the idea that NKA is primarily a Na+-pump.
Side-chain positions and conformations are very similar to
those in the Ca2+-binding sites of SERCA1a, except for
Asn783. In NKA, the side-chain conformation of Asn783 is fixed
differently from that in SERCA1a by a hydrogen bondwith Tyr854
on the kinked part of the M7 helix (M70) (Figure 2C). NKA
a-subunit M5 is also partially unwound and kinked. This kink,
produced by Pro785, is critical for making space and providing
the main-chain carbonyl of Thr799 for K+ coordination (Fig-
ure 2B). In SERCA1a, the residue corresponding to Pro785 is
Gly770; theM5 helix is certainly kinked but continuous, providing
little extra space. As a result, the amide of Asn768 in SERCA1a
(Asn783 in shark NKA) would come too close to site I K+
(double-headed arrow in Figure 2B) and the side chain to site II
K+. Thus, the crystal structure explains why K+ can bind to
NKA but not to SERCA1a. Unwinding of M7 in the NKA a-subunitStructureis stabilized by hydrogen bonding of Tyr44 of the b-subunit to the
Gly855 carbonyl, which otherwise would be exposed to the
hydrophobic core of the bilayer (Figure 2C). Interestingly, in
NKA, a cholesterol molecule is identified here, apparently shield-
ing the unwound part of M7 from the bulk lipid. Except for the
b-adrenergic receptors (Hanson et al., 2008), NKA is so far the
only example in which cholesterol is identified in the crystal
structure of membrane proteins. This cholesterol molecule is
stacked with the side chain of Tyr40 of the b-subunit, the
hydroxyl of which forms a hydrogen bond with Gln856 on the
a-subunit M7. The residues contacting cholesterol are highly
conserved (Adamian et al., 2011), suggesting an important role
for this cholesterol (Cornelius et al., 2003).
Architecture of NKA: The b-Subunit
The primary role of the b-subunit is to act as a molecular chap-
erone. Association of the b-subunit with newly synthesized
a facilitates routing to and insertion into the plasma membrane,
thereby conferring conformational stability on the a-subunit
(Geering, 2001; Geering, 2008). The b-subunit also modulates
functional properties of the NKA, including cation binding affinity
(Geering, 2001) and K+-occlusion (Lutsenko and Kaplan, 1993).
The b-subunit consists of an N-terminal cytoplasmic domain
of approximately 30 residues, one transmembrane helix located
in the groove between the M7 and M10 helices of the a-subunit
and a large extracellular domain (ectodomain) of about 240 resi-
dues that nearly covers the entire extracellular surface of the
a-subunit (Figure 1A). No atomic model is available for the cyto-
plasmic domain, although it probably extends toward the
a-subunit M1 helix (Morth et al., 2007). The extracellular domain
of b is composed of a distorted antiparallel b sheet forming a roll
of an immunoglobulin fold type and a short helix of nine residues
(Figure 3A; Shinoda et al., 2009). The main part of b-subunit
extracellular domain has a fold very similar to adhesion mole-
cules, such as nectin (Bab-Dinitz et al., 2009) stabilized by three
disulfide bonds. Indeed, the b2-subunit functions as an adhering
molecule in glial cells of rat brain (Gloor et al., 1990). Interestingly,
b-subunit has 1-3 bulges and 2-4 potential glycosylation sites,
both of which vary depending on isoforms (Figure 3A) and may
regulate dimerization. For instance, dimer formation of b1 can
be blocked by one specific bulge (residue 190-209), which is
absent in human b2-b3. Also, the sugars might be used directly
in cell-cell contacts (Vagin et al., 2006).
The transmembrane helix of b runs nearly parallel to the M7
helix of the a-subunit and makes numerous contacts with the
M7 and M10 helices of a using two clusters of aromatic residues
(Figure 1C). On the extracellular side, b makes complex interac-
tions with the L7/8 loop of a, which is much shorter than that in
SERCA1a, including the conserved 901SFGQ sequence as the
primary interaction site (Figure 3B). Indeed, such complex a-b
interactions may explain the effects of b on pump kinetics
(Lutsenko and Kaplan, 1993; Hasler et al., 2001).
The FXYD Protein
FXYD proteins are tissue-specific regulators of NKA and modu-
late its kinetic properties by adjusting the apparent affinities
of Na+, K+ and ATP. For instance, FXYD1 from heart
and FXYD10 from shark rectal gland undergo protein kinase
A- and C-dependent phosphorylation, which maximizes Vmax19, December 7, 2011 ª2011 Elsevier Ltd All rights reserved 1735
A B Figure 3. Structure of the b-Subunit and
Interaction with the FXYD Protein
(A) A view from the extracellular side of shark b1,
on which bulges (dotted circles) and potential
glycosylation sites (solid circles) are identified.
They are specific to b1 (purple), b2 (red), and b3
(cyan) isoforms. Numbers refer to amino acid
residue numbers in shark b1.
(B) Details of the interface with the a-subunit and
FXYD10 in shark rectal gland NKA. FXYD10 is
homologous to human FXYD1 (phospholemman).
Common structural motifs appear within boxes.(Mahmmoud et al., 2000). FXYD1 has also been demonstrated to
associate with and regulate the Na+/Ca2+ exchanger (Cheung
et al., 2007) and L-type Ca2+-channels (Wang et al., 2010) in
heart.
FXYD proteins consist of a single transmembrane helix, an
extracellular (N-terminal) part that contains the FXYD(Y) motif
and a cytoplasmic part containing the phosphorylation sites in
FXYD1 and FXYD10 (Figure 3B). The structural role of the
FXYD(Y) motif, which was obscure in the NMR structures of iso-
lated FXYDs (Franzin et al., 2007), was clarified by the crystal
structure of shark NKA. This motif is located just prior to the
transmembrane helix, and the starting Phe12 anchors the
segment to the b-subunit through stacking interactions with
the b-subunit Phe187. Two Tyr residues (Y14 and Y16) in the
motif form an aromatic cluster with a Tyr residue in b (Y69) and
a Trp residue (W987) in a, thereby sandwiching the b-subunit
with a (Figure 3B). Asp15, the last residue in the FXYD motif,
caps the TM helix. The residues flanking the motif form
a hydrogen-bonding network involving both a- and b-subunits.
Thus the FXYD(Y) motif seems to be important for stabilizing
a-b-FXYD interaction. Indeed, stability of human a2/b1 complex
is substantially improved by adding FXYD1 (Lifshitz et al., 2007).
However, this improvementmay also be attributed to retention of
a particular phospholipid molecule, phosphatidylserine, which is
associated with the a-subunit (Mishra et al., 2011). It is certainly
true that lipid-facing residues in this region are highly conserved
and that we can identify there electron density that may repre-
sent a phospholipid molecule. Nevertheless, there is no clear
picture yet on how various FXYD proteins affect binding of
Na+/K+ and the kinetic properties of NKA. For this, we need to
visualize the cytoplasmic part of FXYD protein, including the
phosphorylation sites.
Binding Site of Cardiotonic Steroids
CTS bind to the extracellular side of NKA with sub-nanomolar Kd
in the most efficient cases, promoted (albeit not exclusively) by
enzyme phosphorylation (see Forbush, 1983 and Glynn, 1985
for a review). It is well established that K+ antagonizes CTS
binding by accelerating the transition of E2P / E2$2K+, but
CTS binding stabilizes occlusion of K+ in E2$2K+, though the
affinity is low (mM Kd). CTS binding has a fast and a slow phase,1736 Structure 19, December 7, 2011 ª2011 Elsevier Ltd All rights reservedand the latter may take more than
several hours. Under physiological condi-
tions, CTS are thought to stabilize the
E2P$2Na+ state, judging from the fluores-
cence signal of RH421 (Stu¨rmer andApell, 1992); however, to the best of our knowledge, no direct
demonstration exists. In fact, the ATPase-ouabain complexes
formed by the forward (phosphorylation by ATP) and backward
(phosphorylation by Pi) reactions may have different properties
(e.g., dissociation rate of CTS; Forbush, 1983). Because most
of these studies were performed in the early 1980s, these state-
ments may require re-evaluation following the use of stable
phosphate analogs, although more recent results are in no
contradiction with previous proposals (Cornelius et al., 2011;
Yatime et al., 2011).
In general, CTS molecules are composed of three major
components: a 5- or 6-membered lactone, a steroid core, and
a sugar moiety of 1-4 sugar residues (Figure 4). Ouabain has
a five-membered lactone and rhamnose as the carbohydrate.
Ouabain is one of the most soluble CTS because of its several
hydroxyl groups attached on the b surface of the steroid core.
There is an enormous body of literature on the structure-activity
relationship of natural CTS and their derivatives (e.g., Paula
et al., 2005). Essential features important for CTS activity estab-
lished from those studies are: (1) an unsaturated lactone ring
attached at C17, (2) a steroid nucleus in chair configuration, (3)
the presence of a hydroxyl group at C14, and (4) the presence
of an appropriate sugar at C3 (Glynn, 1985).
The crystal structure of the shark enzyme in E2$2K+$MgF4
2
soaked with 20 mM ouabain and solved at 2.8 A˚ resolution
(Figure 1A; Ogawa et al., 2009) explains why these features are
important, and, furthermore, how K+ reduces the affinity of
ouabain to a millimolar level. In the crystal structure, an ouabain
molecule is deeply wedged into the TM domain so that the
lactone ring comes very close to the K+ binding sites, partially
unwinding the a-subunit M4 helix, and the rhamnose moiety
interacts with the L7/8 loop of the a-subunit (Figures 1A and 4).
This is in clear contradiction to the previous assumption that
CTS bind to the extracellular surface more or less tangentially
(Keenan et al., 2005; Yatime et al., 2009); nevertheless, it
explains whymany residues identified by extensive mutagenesis
studies are critical (Croyle et al., 1997; De Pont et al., 2009).
Unwinding of the M4 helix in a requires the lactone ring to
displace Gly326 on M4 and substitute the Gly326 carbonyl
with that on the lactone ring for hydrogen bonding (Figure 4).
Therefore, it is easy to see that correct positioning of the lactone
Figure 4. Ouabain Binding Site in NKA
Details of ouabain binding to shark rectal gland NKA at low affinity viewed
approximately parallel to the membrane. Water-accessible surface in atom
color is superimposed with the atomic model. Green dotted lines show likely
hydrogen bonds. Inset shows a diagram of ouabain.carbonyl is critical and that bound K+ will hinder the binding of
CTS. On the other hand, the release of bound K+ is blocked by
ouabain (Cornelius et al., 2011). The steroid core stacks with
three Phe residues on two a-subunit helices, M4 and M5, which
requires that the core is in a chair configuration. The hydroxyl
attached to C14 of ouabain forms a hydrogen bond with
Thr804 located near the extracellular end of a-subunit M6.
Rhamnose appears to form hydrogen bonds with residues at
the extracellular surface of M4 and L7/8 of the a-subunit. Initially,
the binding cavity for ouabain is not large enough and has to be
opened by a rearrangement of TM helices. In the low-affinity
form, as movements of the M1 and M2 helices of the a-subunit
are highly restricted by bound K+, a complementary surface is
formed only to the a-side of the steroid core (or M4-M6 side).
However, without bound K+, that is, in the high-affinity form, it
is expected that theM1-M2 helices of the a-subunit comes close
enough to form hydrogen bonds with the hydroxyls on the b-side
and those on rhamnose. The low-resolution (4.6 A˚) crystal struc-
ture without K+ (E2P$nH+$ouabain) has confirmed these expec-
tations (Yatime et al., 2011). As the residues surrounding the
steroid core are highly conserved, those interacting with the
sugar moiety appear to be the only possible place for conferring
isoform specificity. This idea is in accordwith a recent systematic
studyonstructure-isoformdependenceofCTS (Katz et al., 2010).
Conclusions
The crystal structure of NKA at 2.4 A˚ resolution in the
E2$2K+$MgF4
2 state showed remarkable similarity to SERCA1a
in general design, but also many unexpected structural differ-
ences. We have described some of them in this short review,
but there are many more. For instance, the cytoplasmic head-
piece is much more loosely organized in NKA: the A- andStructureN-domains are more detached and have only one hydrogen
bond between them. Even the orientation of the A-domain is
different with respect to the P-domain. Possibly related to this,
TM helices M1-M4 occupy very much the same positions, but
with different orientations (Figure 1C). These features may be
related to a difference in turnover number, which will be one of
the key questions that await structural explanation.When looking
at the SERCA1a structure, we originally thought that site II is
specific to Ca2+, as the structure is reminiscent of the EF-hand.
However, we now see K+ at the same position with even one
more acidic residue (Asp811 in NKA, instead of Asn796 in
SERCA1a; Figure 2A). Thus, how these two P-type ATPases
are evolutionarily related is becoming an even more interesting
topic to explore. Nevertheless, structural study on NKA has just
started, and although its crystallization is still a great challenge,
future studies will certainly provide us with many more surprises.
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